Apr 29 2010
DFine, Inc., a developer of minimally invasive solutions for treating vertebral compression fractures, announced today that the United States Patent & Trademark Office has issued Patent 7,678,116 relating to the StabiliT® Vertebral Augmentation System. Two additional Notices of Allowance have also been issued with patents expected later this year.
“I am pleased with our expanding patent portfolio”
"I am pleased with our expanding patent portfolio," said Kevin Mosher, Chief Executive Officer of DFine, Inc. "DFine has a number of innovative technologies and concepts that will provide the basis for future pipeline products and further enhance the value of our patent portfolio. Combined with our global commercialization efforts, our underlying intellectual property uniquely positions DFine as the technology leader in the treatment of vertebral compression fractures and other vertebral pathologies."
DFine has more than fifty additional patent applications pending in the U.S. Patent & Trademark Office related to the StabiliT® Vertebral Augmentation System used in the treatment of vertebral compression fractures with several new products under development.